See analyst estimates and all valuation multiples for Drug Delivery Systems
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $20.2B | n/a | n/a | |
| $11.0B | n/a | n/a | |
| $6.0B | 4.4x | 17.5x | |
| $3.9B | n/a | n/a | |
| $3.6B | 13.7x | 33.3x | |
| $2.8B | n/a | n/a | |
| $2.7B | 2.3x | 8.2x | |
| $2.7B | n/a | n/a | |
| $2.3B | n/a | n/a | |
| $1.6B | 4.6x | n/a | |
| $1.3B | n/a | n/a | |
| $971M | 28.5x | -135.8x | |
| $945M | n/a | n/a | |
| $708M | n/a | n/a | |
| $576M | 15.2x | 58.4x | |
| $452M | n/a | n/a | |
| $330M | n/a | n/a | |
| $316M | n/a | n/a | |
| $263M | n/a | n/a | |
| $216M | n/a | n/a | |
| $146M | 28.0x | n/a | |
| $132M | n/a | n/a | |
| $110M | 3.4x | -0.7x | |
| $108M | n/a | n/a | |
| $104M | 4.7x | -83.3x | |
| $97.7M | 3.9x | n/a | |
| $93.5M | 13.2x | -26.5x | |
| $91.8M | 24.8x | -4.1x | |
| $72.8M | 1733.4x | n/a | |
| $65.1M | n/a | n/a | |
| $65.0M | n/a | n/a | |
| $57.9M | n/a | n/a | |
| $53.2M | n/a | n/a | |
| $48.9M | 18.1x | n/a | |
| $34.2M | n/a | n/a | |
| $33.6M | n/a | n/a | |
| $29.3M | 31.1x | n/a | |
| $20.8M | 16.4x | n/a | |
| $14.4M | n/a | n/a | |
| $11.6M | n/a | n/a | |
| $2.0M | n/a | n/a | |
| -$18.0M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Drug Delivery Systems